Evidence map›Paper›PMID 38065475›Full record

ArticleJournal of affective disorders2024

Longitudinal risk of suicide outcomes in people with severe mental illness following an emergency department visit and the effects of suicide prevention treatment.

Ana Rabasco, Sarah Arias, Madeline B Benz, Lauren M Weinstock, Ivan Miller, Edwin D Boudreaux, Carlos A Camargo, Zachary J Kunicki, Brandon A Gaudiano

Open access · greenAbstract read
In one paragraph

Article in Journal of affective disorders, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Ana RabascoWarren Alpert Medical School of Brown University, Providence, RI, USA; Butler Hospital, Providence, RI, USA. Electronic address: ana_rabasco@brown.edu.
Sarah AriasWarren Alpert Medical School of Brown University, Providence, RI, USA; Butler Hospital, Providence, RI, USA.
Madeline B BenzWarren Alpert Medical School of Brown University, Providence, RI, USA; Butler Hospital, Providence, RI, USA.
Lauren M WeinstockWarren Alpert Medical School of Brown University, Providence, RI, USA.
Ivan MillerWarren Alpert Medical School of Brown University, Providence, RI, USA; Butler Hospital, Providence, RI, USA.
Edwin D BoudreauxUniversity of Massachusetts Chan Medical School, Worcester, MA, USA.
Carlos A CamargoMassachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Zachary J KunickiWarren Alpert Medical School of Brown University, Providence, RI, USA.
Brandon A GaudianoWarren Alpert Medical School of Brown University, Providence, RI, USA; Butler Hospital, Providence, RI, USA.
Providence College · USBrown University · USHarvard University · USUniversity of Massachusetts Chan Medical School · US

Funding

The Center for Accelerating Practices to End Suicide through Technology Translation (CAPES)P50MH129701 · NIMH · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Edwin D Boudreaux · 2023 to 2026
$16.2M
Emergency Department Safety Assessment and Follow-Up Evaluation (EDSAFE) TrialU01MH088278 · NIMH · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI BOUDREAUX, EDWIN D, CAMARGO, CARLOS ARTURO · 2009 to 2013
$11.7M
Postdoctoral Training in Suicide ResearchT32MH126426 · NIMH · BROWN UNIVERSITY · PI IVAN W. MILLER, LAUREN M WEINSTOCK · 2021 to 2026
$1.8M
NIMH NIH HHS P50 MH129701NIMH NIH HHS T32 MH126426NIMH NIH HHS U01 MH088278
6 · The paper itself

Abstract

backgroundIndividuals with severe mental illness (SMI), including bipolar disorder (BD) and schizophrenia-spectrum disorders (SSD), are at high risk for suicide. However, suicide research often excludes individuals with SMI. The current research examined differences in suicide outcomes (i.e., suicide attempt or death) for adults with and without BD and SSD diagnoses following an emergency department (ED) visit and investigated the efficacy of the Coping Long Term with Active Suicide Program (CLASP) intervention in reducing suicide outcomes among people with SMI.

methods1235 adults presenting with recent suicidality were recruited from 8 different EDs across the United States. Using a quasi-experimental, stepped wedge series design, participants were followed for 52-weeks with or without subsequent provision of CLASP.

resultsParticipants in the SSD group and the BD group had significantly shorter time to and higher rate of suicide outcomes than participants with other psychiatric diagnoses in all study phases and in non-CLASP phases, respectively. Participants with BD receiving the CLASP intervention had significantly longer time to suicide outcomes than those not receiving CLASP; these differences were not observed among those with SSD. LIMITATIONS: Study limitations include self-reported psychiatric diagnosis, exclusion of homeless participants, and small sample size of participants with SSD.

conclusionsParticipants with SMI were at higher risk for suicide outcomes than participants with other psychiatric diagnoses. CLASP was efficacious among those participants with BD. Psychiatric diagnosis may be a key indicator of prospective suicide risk. More intensive and specialized follow-up mental health treatment may be necessary for those with SSD.

Indexed as

Mental DisordersSchizophreniaAdultEmergency Room VisitsHumansProspective StudiesSuicide PreventionUnited StatesBipolar disorderEmergency departmentInterventionSchizophreniaSevere mental illnessSuicide

Identifiers

PMID38065475
PMCPMC10872614
OpenAlexW4389365914

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.